New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
Kaiser Permanente joins phase 3 clinical trial for COVID-19 vaccine
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
Early colorectal cancer screening benefits African Americans
Kaiser Permanente study published in the journal Gastroenterology supports starting screening at age 45 among this higher-risk population.
Living longer and better after cancer
Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.
On-demand HIV prevention pills worked well, study shows
Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication.